Jan 15, 2020 / 03:30PM GMT
Tycho W. Peterson - JP Morgan Chase & Co, Research Division - Senior Analyst
Okay. Good morning. We're going to go ahead and kick it off. I'm Tycho Peterson from the Life Science team. Welcome to Day 3 of the conference. It's my pleasure to introduce our first company this morning, Invitae. We'll do a breakout right after in the Georgian room across the hall.
And with that, let me turn it over to Sean.
Sean E. George - Invitae Corporation - Co-Founder, President, CEO & Chairman
Thanks, Tycho, and thanks again for the opportunity. Thank you all. I know it's early morning, Day 3. I appreciate the audience. As usual, I'll be making some forward-looking statements. I refer you to the IR section of our website, before we get going.
Genetic information is the most fundamental of personal health information. In the few minutes we have here today, I'd like to share with you our views -- our continuing views on, a, just how fundamental it is; and maybe more importantly, just how large the opportunity is, that we see as a business to harness it
Invitae Corp at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot